Your browser doesn't support javascript.
loading
Tumor-infiltrating Leukocyte Profiling Defines Three Immune Subtypes of NSCLC with Distinct Signaling Pathways and Genetic Alterations.
Aoki, Kazunori; Nishito, Yukari; Motoi, Noriko; Arai, Yasuhito; Hiraoka, Nobuyoshi; Shibata, Tatsuhiro; Sonobe, Yukiko; Kayukawa, Yoko; Hashimoto, Eri; Takahashi, Mina; Fujii, Etsuko; Nishizawa, Takashi; Fukuda, Hironori; Ohashi, Kana; Arai, Kosuke; Mizoguchi, Yukihiro; Yoshida, Yukihiro; Watanabe, Shun-Ichi; Yamashita, Makiko; Kitano, Shigehisa; Sakamoto, Hiromi; Nagata, Yuki; Mitsumori, Risa; Ozaki, Kouichi; Niida, Shumpei; Kanai, Yae; Hirayama, Akiyoshi; Soga, Tomoyoshi; Maruyama, Toru; Tsukada, Keisuke; Yabuki, Nami; Shimada, Mei; Kitazawa, Takehisa; Natori, Osamu; Sawada, Noriaki; Kato, Atsuhiko; Yoshida, Teruhiko; Yasuda, Kazuki; Mizuno, Hideaki; Tsunoda, Hiroyuki; Ochiai, Atsushi.
Afiliação
  • Aoki K; Department of Immune Medicine, National Cancer Center Research Institute, Chuo-ku, Tokyo, Japan.
  • Nishito Y; Kamakura Research Laboratories, Chugai Pharmaceutical Co., Ltd., Kamakura, Kanagawa, Japan.
  • Motoi N; Department of Diagnostic Pathology, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan.
  • Arai Y; Divison of Cancer Genomics, National Cancer Center Research Institute, Chuo-ku, Tokyo, Japan.
  • Hiraoka N; Department of Analytical Pathology, National Cancer Center Research Institute, Chuo-ku, Tokyo, Japan.
  • Shibata T; Divison of Cancer Genomics, National Cancer Center Research Institute, Chuo-ku, Tokyo, Japan.
  • Sonobe Y; Kamakura Research Laboratories, Chugai Pharmaceutical Co., Ltd., Kamakura, Kanagawa, Japan.
  • Kayukawa Y; Kamakura Research Laboratories, Chugai Pharmaceutical Co., Ltd., Kamakura, Kanagawa, Japan.
  • Hashimoto E; Kamakura Research Laboratories, Chugai Pharmaceutical Co., Ltd., Kamakura, Kanagawa, Japan.
  • Takahashi M; Kamakura Research Laboratories, Chugai Pharmaceutical Co., Ltd., Kamakura, Kanagawa, Japan.
  • Fujii E; Kamakura Research Laboratories, Chugai Pharmaceutical Co., Ltd., Kamakura, Kanagawa, Japan.
  • Nishizawa T; Kamakura Research Laboratories, Chugai Pharmaceutical Co., Ltd., Kamakura, Kanagawa, Japan.
  • Fukuda H; Department of Immune Medicine, National Cancer Center Research Institute, Chuo-ku, Tokyo, Japan.
  • Ohashi K; Department of Immune Medicine, National Cancer Center Research Institute, Chuo-ku, Tokyo, Japan.
  • Arai K; Department of Immune Medicine, National Cancer Center Research Institute, Chuo-ku, Tokyo, Japan.
  • Mizoguchi Y; Department of Immune Medicine, National Cancer Center Research Institute, Chuo-ku, Tokyo, Japan.
  • Yoshida Y; Department of Thoracic Surgery, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan.
  • Watanabe SI; Department of Thoracic Surgery, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan.
  • Yamashita M; Advanced Medical Development Center, Cancer Research Hospital, Japanese Foundation for Cancer Research, Koto-ku, Tokyo, Japan.
  • Kitano S; Advanced Medical Development Center, Cancer Research Hospital, Japanese Foundation for Cancer Research, Koto-ku, Tokyo, Japan.
  • Sakamoto H; Department of Clinical Genomics, National Cancer Center Research Institute, Chuo-ku, Tokyo, Japan.
  • Nagata Y; Medical Genome Center, Research Institute, National Center for Geriatrics and Gerontology, Obu, Aichi, Japan.
  • Mitsumori R; Bioresource Research Center, Graduate School of Medical and Dental Science, Tokyo Medical and Dental University, Bunkyo-ku, Tokyo, Japan.
  • Ozaki K; Medical Genome Center, Research Institute, National Center for Geriatrics and Gerontology, Obu, Aichi, Japan.
  • Niida S; Medical Genome Center, Research Institute, National Center for Geriatrics and Gerontology, Obu, Aichi, Japan.
  • Kanai Y; Medical Genome Center, Research Institute, National Center for Geriatrics and Gerontology, Obu, Aichi, Japan.
  • Hirayama A; Department of Pathology, School of Medicine, Keio University, Sinjyuku-ku, Tokyo, Japan.
  • Soga T; Institute for Advanced Biosciences, Keio University Tsuruoka, Yamagata, Japan.
  • Maruyama T; Institute for Advanced Biosciences, Keio University Tsuruoka, Yamagata, Japan.
  • Tsukada K; Kamakura Research Laboratories, Chugai Pharmaceutical Co., Ltd., Kamakura, Kanagawa, Japan.
  • Yabuki N; Kamakura Research Laboratories, Chugai Pharmaceutical Co., Ltd., Kamakura, Kanagawa, Japan.
  • Shimada M; Kamakura Research Laboratories, Chugai Pharmaceutical Co., Ltd., Kamakura, Kanagawa, Japan.
  • Kitazawa T; Kamakura Research Laboratories, Chugai Pharmaceutical Co., Ltd., Kamakura, Kanagawa, Japan.
  • Natori O; Kamakura Research Laboratories, Chugai Pharmaceutical Co., Ltd., Kamakura, Kanagawa, Japan.
  • Sawada N; Kamakura Research Laboratories, Chugai Pharmaceutical Co., Ltd., Kamakura, Kanagawa, Japan.
  • Kato A; Kamakura Research Laboratories, Chugai Pharmaceutical Co., Ltd., Kamakura, Kanagawa, Japan.
  • Yoshida T; Kamakura Research Laboratories, Chugai Pharmaceutical Co., Ltd., Kamakura, Kanagawa, Japan.
  • Yasuda K; Department of Genetic Medicine and Services, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan.
  • Mizuno H; National Center for Global Health and Medicine, Shinjuku-ku, Tokyo, Japan.
  • Tsunoda H; Kamakura Research Laboratories, Chugai Pharmaceutical Co., Ltd., Kamakura, Kanagawa, Japan.
  • Ochiai A; Kamakura Research Laboratories, Chugai Pharmaceutical Co., Ltd., Kamakura, Kanagawa, Japan.
Cancer Res Commun ; 3(6): 1026-1040, 2023 06.
Article em En | MEDLINE | ID: mdl-37377611
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Limite: Humans Idioma: En Revista: Cancer Res Commun Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Japão
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Limite: Humans Idioma: En Revista: Cancer Res Commun Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Japão